OppenheimerFunds, Inc. - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 163 filers reported holding WUXI PHARMATECH CAYMAN INC in Q1 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
OppenheimerFunds, Inc. ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$170,766,000
+82.0%
3,952,017
+78.0%
0.23%
+113.9%
Q2 2015$93,814,000
+97.2%
2,219,918
+80.9%
0.11%
+103.8%
Q1 2015$47,583,000
+20.6%
1,227,002
+4.7%
0.05%
+20.5%
Q4 2014$39,459,000
-3.9%
1,171,9340.0%0.04%
-2.2%
Q3 2014$41,041,000
+19.7%
1,171,934
+12.3%
0.04%
+18.4%
Q2 2014$34,287,000
+1.1%
1,043,440
+13.5%
0.04%
-5.0%
Q1 2014$33,898,000
-0.3%
919,640
+3.8%
0.04%
-2.4%
Q4 2013$34,007,000
+98.3%
886,050
+41.6%
0.04%
+78.3%
Q3 2013$17,146,000
+30.5%
625,7500.0%0.02%
+21.1%
Q2 2013$13,141,000625,7500.02%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q1 2014
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 241,186$9,353,00020.89%
Sensato Investors LLC 672,513$26,080,0005.62%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 2,781,889$107,882,0003.77%
Sloane Robinson LLP 57,500$2,230,0003.35%
Grandeur Peak Global Advisors, LLC 344,518$13,360,0002.83%
THOMAS WHITE INTERNATIONAL LTD 474,694$18,409,0002.58%
Granite Point Capital Management, L.P. 180,000$6,980,0002.56%
COMGEST GLOBAL INVESTORS S.A.S. 2,058,180$79,816,0002.49%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 234,071$9,077,0002.47%
DECADE CAPITAL MANAGEMENT LLC 389,735$15,114,0001.87%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders